22-02. Dr. M Scholz "Current Management of Prostate Cancer" Feb. 24, 2022

22-02. Dr. M Scholz "Current Management of Prostate Cancer" Feb. 24, 2022Подробнее

Relapsed Prostate Cancer: Treatments, Side Effects, & Imaging | Mark Scholz, MD | PCRIПодробнее

Your Overall Health Matters as Much as Your Prostate Cancer Care | Mark Moyad, MD & Mark Scholz, MDПодробнее

The Four Levels of #ProstateCancer Treatment Intensity | #markscholzmd #alexscholz @ThePCRIПодробнее

The Over-treatment of Prostate Cancer with Dr. Mark ScholzПодробнее

BRCA Testing and Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDПодробнее

Metastatic #ProstateCancer Treatment Case Study | #MarkScholzMD #AlexScholz #PCRIПодробнее

ESOU Online: EAU22 highlights in prostate cancerПодробнее

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRIПодробнее

Remission and Cure After Relapse Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

The Pros and Cons of Proton Therapy | Mark Scholz, MD | PCRIПодробнее

Lymphedema After Prostate Cancer Treatment | Ask a Prostate Expert, Mark Scholz, MDПодробнее

Radiation and Hormone Therapy | Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

How Much Time Do You Have to Treat #ProstateCancer? | #MarkScholzMD #AlexScholz #PCRIПодробнее

Managing Terminal Prostate Cancer | #MarkScholzMD #AlexScholz #PCRIПодробнее

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

How PSA Responds to #ProstateCancer Treatment | #MarkScholzMD #AlexScholz #PCRIПодробнее

22-11. Prof. Leonard Marks MD. "Contemporary Management of Prostate Cancer"Подробнее

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRIПодробнее

Treating High-Risk Gleason 8: A Modern Approach | Mark Scholz, MD | PCRIПодробнее